News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
309,366 Results
Type
Article (11706)
Company Profile (119)
Press Release (297541)
Multimedia
Podcasts (12)
Webinars (6)
Section
Business (101905)
Career Advice (740)
Deals (17159)
Drug Delivery (48)
Drug Development (25200)
Employer Resources (39)
FDA (5285)
Job Trends (7664)
News (152190)
Policy (12444)
Tag
Academia (1330)
Academic (1)
Accelerated approval (1)
Adcomms (6)
Allergies (32)
Alliances (30747)
ALS (21)
Alzheimer's disease (561)
Antibody-drug conjugate (ADC) (35)
Approvals (5314)
Artificial intelligence (184)
Autoimmune disease (9)
Automation (10)
Bankruptcy (139)
Best Places to Work (6597)
BIOSECURE Act (11)
Biosimilars (26)
Biotechnology (82)
Bladder cancer (25)
Brain cancer (10)
Breast cancer (119)
Cancer (946)
Cardiovascular disease (64)
Career advice (631)
Career pathing (13)
CAR-T (43)
Cell therapy (156)
Cervical cancer (7)
Clinical research (20216)
Collaboration (549)
Compensation (319)
Complete response letters (7)
COVID-19 (850)
CRISPR (21)
C-suite (116)
Cystic fibrosis (35)
Data (898)
Decentralized trials (1)
Denatured (5)
Depression (9)
Diabetes (85)
Diagnostics (3575)
Digital health (12)
Diversity (3)
Diversity, equity & inclusion (12)
Drug discovery (94)
Drug pricing (67)
Drug shortages (4)
Duchenne muscular dystrophy (27)
Earnings (34389)
Editorial (18)
Employer branding (3)
Employer resources (33)
Events (41879)
Executive appointments (422)
FDA (5820)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (354)
Gene editing (37)
Generative AI (15)
Gene therapy (106)
GLP-1 (247)
Government (2346)
Grass and pollen (3)
Guidances (37)
Healthcare (10540)
Huntington's disease (8)
IgA nephropathy (2)
Immunology and inflammation (35)
Indications (10)
Infectious disease (904)
Inflammatory bowel disease (63)
Inflation Reduction Act (6)
Influenza (20)
Intellectual property (33)
Interviews (111)
IPO (7561)
IRA (32)
Job creations (1333)
Job search strategy (543)
Kidney cancer (2)
Labor market (19)
Layoffs (134)
Leadership (5)
Legal (2464)
Liver cancer (19)
Lung cancer (134)
Lymphoma (61)
Machine learning (4)
Management (11)
Manufacturing (188)
MASH (19)
Medical device (5371)
Medtech (5373)
Mergers & acquisitions (9904)
Metabolic disorders (204)
Multiple sclerosis (19)
NASH (3)
Neurodegenerative disease (35)
Neuropsychiatric disorders (3)
Neuroscience (739)
NextGen: Class of 2025 (3774)
Non-profit (2957)
Now hiring (10)
Obesity (96)
Opinion (78)
Ovarian cancer (24)
Pain (26)
Pancreatic cancer (27)
Parkinson's disease (60)
Partnered (14)
Patents (68)
Patient recruitment (36)
Peanut (17)
People (30608)
Pharmaceutical (24)
Pharmacy benefit managers (8)
Phase I (6813)
Phase II (8545)
Phase III (6385)
Pipeline (603)
Policy (90)
Postmarket research (680)
Preclinical (3250)
Press Release (70)
Prostate cancer (38)
Psychedelics (11)
Radiopharmaceuticals (121)
Rare diseases (114)
Real estate (3662)
Recruiting (15)
Regulatory (8519)
Reports (16)
Research institute (1419)
Resumes & cover letters (100)
Rett syndrome (1)
RNA editing (1)
RSV (8)
Schizophrenia (20)
Series A (54)
Series B (34)
Service/supplier (14)
Sickle cell disease (22)
Special edition (6)
Spinal muscular atrophy (84)
Sponsored (16)
Startups (1774)
State (1)
Supply chain (40)
Tariffs (11)
The Weekly (7)
Vaccines (165)
Venture capitalists (15)
Weight loss (52)
Women's health (12)
Worklife (6)
Date
Today (77)
Last 7 days (342)
Last 30 days (1145)
Last 365 days (14838)
2025 (4701)
2024 (16177)
2023 (18875)
2022 (26301)
2021 (27528)
2020 (27119)
2019 (25659)
2018 (19376)
2017 (14750)
2016 (14081)
2015 (15835)
2014 (11449)
2013 (9614)
2012 (10545)
2011 (11252)
2010 (10093)
Location
Africa (296)
Alabama (22)
Alaska (5)
Arizona (78)
Arkansas (9)
Asia (16534)
Australia (2433)
California (2588)
Canada (1233)
China (263)
Colorado (147)
Connecticut (136)
Delaware (106)
Europe (40807)
Florida (361)
Georgia (66)
Hawaii (1)
Idaho (23)
Illinois (292)
India (13)
Indiana (205)
Iowa (3)
Japan (82)
Kansas (35)
Kentucky (14)
Louisiana (8)
Maine (29)
Maryland (552)
Massachusetts (1975)
Michigan (92)
Minnesota (141)
Mississippi (2)
Missouri (56)
Montana (21)
Nebraska (12)
Nevada (26)
New Hampshire (25)
New Jersey (688)
New Mexico (18)
New York (659)
North Carolina (503)
North Dakota (6)
Northern California (1200)
Ohio (114)
Oklahoma (10)
Oregon (10)
Pennsylvania (585)
Puerto Rico (8)
Rhode Island (20)
South America (467)
South Carolina (5)
Southern California (943)
Tennessee (55)
Texas (389)
United States (10161)
Utah (69)
Virginia (61)
Washington D.C. (23)
Washington State (203)
West Virginia (3)
Wisconsin (34)
309,366 Results for "alivamab discovery services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Ablexis and AlivaMab Discovery Services Announce Expansion of Antibody Drug Discovery and Engineering Capabilities
Ablexis, LLC and AlivaMab Discovery Services, LLC announced an expansion of platforms and capabilities in antibody drug discovery and engineering.
November 15, 2022
·
4 min read
Business
AlivaMab Discovery Services Reappoints Dr. Larry Green as Chief Executive Officer
AlivaMab Discovery Services, a leader in the discovery of superior antibody-based therapeutics, announced that Larry Green has reassumed the role of Chief Executive Officer, effective immediately.
September 23, 2022
·
2 min read
Business
AlivaMab Discovery Services Expands Discovery Agreement with IGM Biosciences
AlivaMab Discovery Services, a leader in the discovery of superior antibody therapeutics, announced an expanded agreement with IGM Biosciences.
November 1, 2021
·
2 min read
Business
AlivaMab Discovery Services Appoints Jane Seagal, PhD, as Vice President of Antibody Discovery
AlivaMab Discovery Services, LLC, a leader in the discovery of superior antibody-based therapeutics, announced Jane Seagal, PhD, has joined the company as Vice President of Antibody Discovery.
January 11, 2022
·
3 min read
Biotech Beach
Ablexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development
Ablexis, LLC and AlivaMab Discovery Services, LLC announced a multi-target licensing agreement between Ablexis and Almirall, S.A., a global biopharmaceutical company focused on skin health, and a research partnership between ADS and Almirall.
January 31, 2022
·
5 min read
Business
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals Agreement aims to accelerate the discovery of new therapeutics
September 14, 2021
·
2 min read
Deals
Genentech Offers up to $765M in Biobucks to Repertoire for I&I Drug Discovery
Roche’s Genentech is betting on the Flagship Pioneering–founded company’s discovery platform called DECODE to find new targets for an undisclosed autoimmune disorder.
April 23, 2025
·
1 min read
·
Dan Samorodnitsky
Selvita launches biologic drug discovery and development services
Selvita S.A. announced a strategic initiative to significantly expand its services portfolio and enter the field of biologic drug discovery and development, by adding comprehensive therapeutic antibody discovery and development capabilities to its portfolio.
March 18, 2024
·
4 min read
Press Releases
Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics
January 31, 2025
·
2 min read
Press Releases
Axcelead DDP Enters into Drug Discovery Service Agreement with Astellas for Targeted Protein Degraders
December 26, 2024
·
1 min read
1 of 30,937
Next
